PhytoHealth Corporation is a Taiwan company principally engaged in the research, development and manufacture of new botanical drugs. The Company's main products include western medicines, Chinese herbal medicines, cosmetics, Class B drugs and supplementary food. The Company also provides pharmaceutical consulting services. The Company distributes its products in domestic market and to overseas markets.

Employees

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
11/09/26	TWD 11.10	-1.77%	505,349
10/09/26	TWD 11.30	0.00%	115,785
09/09/26	TWD 11.30	+0.89%	98,783
08/09/26	TWD 11.20	-1.75%	134,299
07/09/26	TWD 11.40	0.00%	120,355

End-of-day quote Taiwan S.E.

More quotes

End-of-day quote Taiwan S.E. 11/09/2026			5-day change	1st Jan Change
11.10 ^TWD	-1.77%		-2.63%	-17.78%

05/08	PhytoHealth Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
03/06	PhytoHealth's Revenue Rises 18% in May	MT

Market Cap	2.2B 69.71M 60.06M 56.87M 51.54M 96.7M 6.66B 97.19M 675M 260M 3.39B 262M 256M 10.71B	P/E 2024	-45.4x	P/E 2025	-46.1x
Enterprise Value	1.16B 36.54M 31.48M 29.81M 27.02M 50.69M 3.49B 50.95M 354M 136M 1.78B 137M 134M 5.61B	EV / Sales 2024	14.8x	EV / Sales 2025	12.1x
Free-Float	75.14%	Yield 2024 *	-	Yield 2025	-

05/08	PhytoHealth Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
03/06	PhytoHealth's Revenue Rises 18% in May	MT
12/05	PhytoHealth Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03/03	PhytoHealth Corporation Reports Earnings Results for the Full Year Ended December 31, 2025	CI
11/11	PhytoHealth Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
22/09/25	PhytoHealth Corporation(TWSE:4108) dropped from S&P Global BMI Index	CI
13/08/25	PhytoHealth Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
06/05/25	PhytoHealth, German Firm to Jointly Market Rectal Pain Drug in EU	MT
05/05/25	PhytoHealth Corporation Signs Letter of Intent with Aristo Pharma GmbH	CI
05/05/25	PhytoHealth Corporation Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
06/03/25	PhytoHealth Corporation Announces Resignation of Wang Der-Shan as Member of Audit Committee and Remuneration Committee	CI
06/03/25	PhytoHealth Corporation Announces Resignation of Wang Der-Shan as Independent Director	CI
27/02/25	PhytoHealth Corporation Reports Earnings Results for the Full Year Ended December 31, 2024	CI

09/08/22	PhytoHealth : BOD approve the 2022 second quarter consolidated financial report	PU
05/07/22	Phytohealth : is invited to Online Investor Conference held by KGI Securities	PU
24/05/22	PhytoHealth : Important resolutions of company's 2022 shareholders' meeting.	PU
08/04/22	PhytoHealth : Public announcement of the progress of company's committed items at the time when stock was listed on Taiwan Stock Exchange.	PU
09/03/22	PhytoHealth : Announcement of the financial information of February 2022	PU

PhytoHealth Corporation Stock

Stocks

4108

TW0004108006

Pharmaceuticals

Valuation : PhytoHealth Corporation

Chart: PhytoHealth Corporation

Latest news : PhytoHealth Corporation

Press Releases : PhytoHealth Corporation

Quotes and Performance

Price Extremes

Managers and Directors : PhytoHealth Corporation

Biopharmaceuticals

Financials

Company Profile

Quotes

1 day	-1.77%
1 week	-2.63%
Current month	-3.90%
3 months	-9.02%
6 months	-17.47%
Current year	-17.78%

1 week	11	11.45
1 month	10.7	12.5
Current year	10.7	15.25
1 year	10.7	16.65
3 years	10.7	24
5 years	10.7	25.25
10 years	10.25	41.05

Manager	Title	Age	Since
I Lin Lee CEO	Chief Executive Officer	-	13/06/2017
Chih Yuan Huang DFI	Director of Finance/CFO	-	11/05/2021
Teng Hsu Wang CTO	Chief Tech/Sci/R&D Officer	-	30/07/2021

Director	Title	Age	Since
Cheng Chia Li CHM	Chairman	-	10/06/2011
Yue Ju Lai BRD	Director/Board Member	-	16/03/2010
Yi Li Lee CHM	Chairman	55	26/05/2020

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PHYTOHEALTH CORPORATION	-1.77%	-2.63%	-31.69%	-44.22%	69.71M
REGENERON PHARMACEUTICALS, INC.	-1.48%	-5.59%	+37.54%	-6.24%	78.02B
CSL LIMITED	-1.42%	-4.24%	-18.81%	-37.78%	57.4B
MODERNA, INC.	+5.38%	-1.09%	+467.03%	+36.08%	57.48B
SAMSUNG BIOLOGICS CO.,LTD.	-0.56%	-2.21%	-11.17%	+25.38%	48.81B
UCB	+1.93%	-2.37%	-2.00%	+149.45%	45.5B
BIOGEN INC.	+0.80%	-1.67%	+45.89%	-16.13%	32.08B
INCYTE CORPORATION	-1.47%	-4.17%	+40.97%	+88.59%	24.62B
INNOVENT BIOLOGICS, INC.	-0.85%	-8.64%	-3.66%	+144.26%	20.77B
SWEDISH ORPHAN BIOVITRUM AB	-0.09%	-3.61%	+63.58%	+97.66%	15.75B
Average	+0.05%	-3.75%	+58.77%	+43.70%	38.05B
Weighted average by Cap.	+0.38%	-3.71%	+82.69%	+35.88%

	2024	2025
Net sales	154M 4.86M 4.18M 3.96M 3.59M 6.74M 464M 6.77M 47.04M 18.09M 236M 18.23M 17.83M 746M	135M 4.25M 3.67M 3.47M 3.15M 5.9M 406M 5.93M 41.23M 15.85M 207M 15.98M 15.63M 653M
Net income	-73.5M -2.32M -2M -1.9M -1.72M -3.22M -222M -3.24M -22.52M -8.66M -113M -8.73M -8.54M -357M	-58.2M -1.84M -1.59M -1.5M -1.36M -2.55M -176M -2.57M -17.83M -6.86M -89.44M -6.91M -6.76M -283M
Net Debt	-1.06B -33.57M -28.93M -27.39M -24.83M -46.58M -3.21B -46.81M -325M -125M -1.63B -126M -123M -5.16B	-1.05B -33.17M -28.58M -27.06M -24.53M -46.01M -3.17B -46.24M -321M -124M -1.61B -125M -122M -5.09B